Introduction:
The first case of COVID-19 emerged in Wuhan, China, in December 2019[1], following which the surge in COVID-19 cases
reached a pandemic proportion by March, 2020. The spectrum of clinical
presentations of COVID-19 include respiratory, cardiac, neurological,
gastrointestinal, renal and ophthalmic involvement[2]. Recent reports have demonstrated the
plausible neuro-invasive potential of SARS-CoV-2
infection[3] and it has also been hypothesized
that SARS-CoV-1 may trigger autoantibody production[4]. Several cases have also documented the
ability of SARS-CoV-2 virus in dysregulation of the immune system, with
COVID-19 cases presenting as Guillain-Barré syndrome[5], Miller Filler syndrome[6], Kawasaki syndrome [7]and antiphospholipid antibody syndrome [4].